Denali Therapeutics
DNLI
#3971
Rank
NZ$5.27 B
Marketcap
NZ$33.78
Share price
-0.25%
Change (1 day)
-6.01%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: NZ$5.27 Billion

As of February 2026 Denali Therapeutics has a market cap of NZ$5.27 Billion. This makes Denali Therapeutics the world's 3971th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.27 B15.97%
2025NZ$4.54 B-13.51%
2024NZ$5.25 B12.15%
2023NZ$4.68 B-21.17%
2022NZ$5.94 B-25.4%
2021NZ$7.97 B-42.72%
2020NZ$13.92 B459.51%
2019NZ$2.48 B-14.67%
2018NZ$2.91 B50.49%
2017NZ$1.93 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Denali Therapeutics was reported to be:

NZ$5.26 Billion
by Nasdaq info icon info icon
NZ$5.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Organovo
ONVO
NZ$6.14 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ$0.63 B-87.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$2.50 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
NZ$2.12 B-59.65% Jersey